Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

Similar articles for PubMed (Select 18625458)

1.

Ketone bodies as a therapeutic for Alzheimer's disease.

Henderson ST.

Neurotherapeutics. 2008 Jul;5(3):470-80. doi: 10.1016/j.nurt.2008.05.004. Review.

PMID:
18625458
2.

Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.

Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S.

Neurobiol Aging. 2004 Mar;25(3):311-4.

PMID:
15123336
3.

Brain uptake and metabolism of ketone bodies in animal models.

Nehlig A.

Prostaglandins Leukot Essent Fatty Acids. 2004 Mar;70(3):265-75. Review.

PMID:
14769485
4.

PET study of 11C-acetoacetate kinetics in rat brain during dietary treatments affecting ketosis.

Bentourkia M, Tremblay S, Pifferi F, Rousseau J, Lecomte R, Cunnane S.

Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E796-801. doi: 10.1152/ajpendo.90644.2008. Epub 2009 Jan 27.

5.

Ketone bodies, potential therapeutic uses.

Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF Jr.

IUBMB Life. 2001 Apr;51(4):241-7. Review.

PMID:
11569918
6.

Medical aspects of ketone body metabolism.

Mitchell GA, Kassovska-Bratinova S, Boukaftane Y, Robert MF, Wang SP, Ashmarina L, Lambert M, Lapierre P, Potier E.

Clin Invest Med. 1995 Jun;18(3):193-216. Review.

PMID:
7554586
7.

KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders.

Smith SL, Heal DJ, Martin KF.

CNS Drug Rev. 2005 Summer;11(2):113-40. Review.

PMID:
16007235
8.

Hypometabolism as a therapeutic target in Alzheimer's disease.

Costantini LC, Barr LJ, Vogel JL, Henderson ST.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S16. doi: 10.1186/1471-2202-9-S2-S16. Review.

9.

The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer.

Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN.

Nutr Metab (Lond). 2007 Feb 21;4:5.

10.

Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer's disease in an NSE/APPsw-transgenic model.

Um HS, Kang EB, Leem YH, Cho IH, Yang CH, Chae KR, Hwang DY, Cho JY.

Int J Mol Med. 2008 Oct;22(4):529-39.

PMID:
18813861
11.

Increased glucose concentration in the hippocampus in early Alzheimer's disease following oral glucose ingestion.

Haley AP, Knight-Scott J, Simnad VI, Manning CA.

Magn Reson Imaging. 2006 Jul;24(6):715-20. Epub 2006 Mar 10.

PMID:
16824966
12.

Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention.

Ding F, Yao J, Rettberg JR, Chen S, Brinton RD.

PLoS One. 2013 Nov 11;8(11):e79977. doi: 10.1371/journal.pone.0079977. eCollection 2013.

13.

Insulin resistance and Alzheimer's disease: molecular links & clinical implications.

Neumann KF, Rojo L, Navarrete LP, Farías G, Reyes P, Maccioni RB.

Curr Alzheimer Res. 2008 Oct;5(5):438-47.

PMID:
18855585
14.

[Alzheimer's disease: new prospects in therapy and applied experimental models].

Kubis AM, Janusz M.

Postepy Hig Med Dosw (Online). 2008 Aug 5;62:372-92. Review. Polish.

15.

Ketones: metabolism's ugly duckling.

VanItallie TB, Nufert TH.

Nutr Rev. 2003 Oct;61(10):327-41. Review.

PMID:
14604265
16.

Cerebral ketone body metabolism.

Morris AA.

J Inherit Metab Dis. 2005;28(2):109-21. Review.

PMID:
15877199
18.

Nerve growth factor in treatment and pathogenesis of Alzheimer's disease.

Williams BJ, Eriksdotter-Jonhagen M, Granholm AC.

Prog Neurobiol. 2006 Oct;80(3):114-28. Epub 2006 Nov 2. Review.

PMID:
17084014
19.

High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.

Phivilay A, Julien C, Tremblay C, Berthiaume L, Julien P, Giguère Y, Calon F.

Neuroscience. 2009 Mar 3;159(1):296-307. doi: 10.1016/j.neuroscience.2008.12.006. Epub 2008 Dec 14.

PMID:
19135506
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk